Health System “Shaken” by Ukraine War 24/08/2022 John Heilprin Six months into the Ukraine war, the World Health Organization warns that the nation’s battered but “still-resilient” health system is facing “severe challenges and shortages in many areas” that must be dealt with as the nation prepares for a challenging winter. WHO officials marked the half-year point in the war, which coincided with Ukraine’s Independence […] Continue reading -> WHO Warns of New Ebola Threat in DRC 23/08/2022 John Heilprin A new case of Ebola has been confirmed in the Democratic Republic of the Congo’s eastern province of North Kivu, prompting health authorities to declare a resurgence of the deadly virus, World Health Organization (WHO) officials said on Tuesday. WHO announced that health authorities confirmed a 46-year-old woman died of the disease on 15 August […] Continue reading -> WHO Advocates Prevention Focus in Africa 23/08/2022 Paul Adepoju & John Heilprin African nations need to pivot to prevention in their fight against disease by “addressing its root causes” through a greater focus on improved diets, healthier environments, and better road safety, among other factors, WHO Director-General Dr Tedros Adhanom Ghebreyesus told the 72nd WHO Regional Committee for Africa meeting, at the opening of the weeklong session of […] Continue reading -> Open Access 240 Compound Collection Launched in Fight Against Infectious and Mosquito-Borne Illnesses for World Mosquito Day 22/08/2022 Raisa Santos To mark World Mosquito Day, 20 August, the Global Health Priority Box has been launched to provide free access to 240 compounds to stimulate research into new drugs and insecticides. The initiative, launched by the Medicines for Malaria Venture (MMV) and the Innovative Vector Control Consortium (IVCC), provides scientists with starting points to advance the […] Continue reading -> WHO Recommends Two Monoclonal Antibodies for Ebola Treatment; Calls to Expand Access in Developing Countries 19/08/2022 John Heilprin In its first guidelines ever for Ebola treatment, the World Health Organization (WHO) advises using two monoclonal antibodies — mAb114 (Ansuvimab®, also known as Ebanga®) and REGN-EB3 (Inmazeb®) — that were first approved by the US Food and Drug Administration for use against the Zaire ebolavirus species in 2020. WHO says its “strong recommendations” for […] Continue reading -> How Can Social Innovation Improve Life in Rural Communities? 19/08/2022 Editorial team When Dr. Magaly Blas, an Associate Professor at the Universidad Peruana Cayetano Heredia in Peru, was researching the association between the human papillomavirus that causes cervical cancer and the human T-lymphotropic virus that causes leukaemia, she found herself travelling often to the Amazon region of Ucayali, home to an indigenous community among whom the disease […] Continue reading -> Monkeypox Cases Spike 20% Weekly Worldwide 17/08/2022 John Heilprin As the first monkeypox case involving a human-to-dog transmission reported, the World Health Organization (WHO) said more than 35,000 recently confirmed cases of monkeypox were accompanied by 12 deaths in 92 nations and territories, including almost 7,500 from last week alone. That made for the second consecutive week with a 20% increase, WHO Director-General Dr […] Continue reading -> Early Neglect of Monkeypox is Rooted in Homophobia 15/08/2022 Michael Weinstein With COVID still upon us, it is hard to fathom why we have waited so long to address monkeypox. A cardinal rule of public health is to catch an emerging epidemic at the first instance it appears. Monkeypox, which was isolated in a few countries in Africa, leapt to Europe in early May and is […] Continue reading -> Exclusive: Manufacturer of World’s Only Monkeypox Drug Says There’s No Shortage; Will Work with WHO on Supplies to LMICs 12/08/2022 Stefan Anderson & Elaine Ruth Fletcher Top executives at Bavarian Nordic, which makes the world’s only monkeypox vaccine, avoided news media in the face of a worldwide shortage of their product. But SIGA, the company behind the antiviral treatment Tecovirimat (TPOXX™), has not been so shy. In an exclusive interview, SIGA’s CEO, Phillip Gomez, says the small, speciality firm is prepared […] Continue reading -> Despite Reforms, WHO ‘Prequalification’ Program for Vital Medicines and Diagnostics Is Inconsistent and Full of Delays 11/08/2022 Raisa Santos & Elaine Ruth Fletcher Recent reforms to the World Health Organization “prequalification” program that certifies the safety and efficacy of health products procured in bulk by donors for low and middle-income countries have speeded up the process and thus accelerated access to lifesaving medicines and diagnostic tools in low- and middle-income countries. However, long lead times for product approvals, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Warns of New Ebola Threat in DRC 23/08/2022 John Heilprin A new case of Ebola has been confirmed in the Democratic Republic of the Congo’s eastern province of North Kivu, prompting health authorities to declare a resurgence of the deadly virus, World Health Organization (WHO) officials said on Tuesday. WHO announced that health authorities confirmed a 46-year-old woman died of the disease on 15 August […] Continue reading -> WHO Advocates Prevention Focus in Africa 23/08/2022 Paul Adepoju & John Heilprin African nations need to pivot to prevention in their fight against disease by “addressing its root causes” through a greater focus on improved diets, healthier environments, and better road safety, among other factors, WHO Director-General Dr Tedros Adhanom Ghebreyesus told the 72nd WHO Regional Committee for Africa meeting, at the opening of the weeklong session of […] Continue reading -> Open Access 240 Compound Collection Launched in Fight Against Infectious and Mosquito-Borne Illnesses for World Mosquito Day 22/08/2022 Raisa Santos To mark World Mosquito Day, 20 August, the Global Health Priority Box has been launched to provide free access to 240 compounds to stimulate research into new drugs and insecticides. The initiative, launched by the Medicines for Malaria Venture (MMV) and the Innovative Vector Control Consortium (IVCC), provides scientists with starting points to advance the […] Continue reading -> WHO Recommends Two Monoclonal Antibodies for Ebola Treatment; Calls to Expand Access in Developing Countries 19/08/2022 John Heilprin In its first guidelines ever for Ebola treatment, the World Health Organization (WHO) advises using two monoclonal antibodies — mAb114 (Ansuvimab®, also known as Ebanga®) and REGN-EB3 (Inmazeb®) — that were first approved by the US Food and Drug Administration for use against the Zaire ebolavirus species in 2020. WHO says its “strong recommendations” for […] Continue reading -> How Can Social Innovation Improve Life in Rural Communities? 19/08/2022 Editorial team When Dr. Magaly Blas, an Associate Professor at the Universidad Peruana Cayetano Heredia in Peru, was researching the association between the human papillomavirus that causes cervical cancer and the human T-lymphotropic virus that causes leukaemia, she found herself travelling often to the Amazon region of Ucayali, home to an indigenous community among whom the disease […] Continue reading -> Monkeypox Cases Spike 20% Weekly Worldwide 17/08/2022 John Heilprin As the first monkeypox case involving a human-to-dog transmission reported, the World Health Organization (WHO) said more than 35,000 recently confirmed cases of monkeypox were accompanied by 12 deaths in 92 nations and territories, including almost 7,500 from last week alone. That made for the second consecutive week with a 20% increase, WHO Director-General Dr […] Continue reading -> Early Neglect of Monkeypox is Rooted in Homophobia 15/08/2022 Michael Weinstein With COVID still upon us, it is hard to fathom why we have waited so long to address monkeypox. A cardinal rule of public health is to catch an emerging epidemic at the first instance it appears. Monkeypox, which was isolated in a few countries in Africa, leapt to Europe in early May and is […] Continue reading -> Exclusive: Manufacturer of World’s Only Monkeypox Drug Says There’s No Shortage; Will Work with WHO on Supplies to LMICs 12/08/2022 Stefan Anderson & Elaine Ruth Fletcher Top executives at Bavarian Nordic, which makes the world’s only monkeypox vaccine, avoided news media in the face of a worldwide shortage of their product. But SIGA, the company behind the antiviral treatment Tecovirimat (TPOXX™), has not been so shy. In an exclusive interview, SIGA’s CEO, Phillip Gomez, says the small, speciality firm is prepared […] Continue reading -> Despite Reforms, WHO ‘Prequalification’ Program for Vital Medicines and Diagnostics Is Inconsistent and Full of Delays 11/08/2022 Raisa Santos & Elaine Ruth Fletcher Recent reforms to the World Health Organization “prequalification” program that certifies the safety and efficacy of health products procured in bulk by donors for low and middle-income countries have speeded up the process and thus accelerated access to lifesaving medicines and diagnostic tools in low- and middle-income countries. However, long lead times for product approvals, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Advocates Prevention Focus in Africa 23/08/2022 Paul Adepoju & John Heilprin African nations need to pivot to prevention in their fight against disease by “addressing its root causes” through a greater focus on improved diets, healthier environments, and better road safety, among other factors, WHO Director-General Dr Tedros Adhanom Ghebreyesus told the 72nd WHO Regional Committee for Africa meeting, at the opening of the weeklong session of […] Continue reading -> Open Access 240 Compound Collection Launched in Fight Against Infectious and Mosquito-Borne Illnesses for World Mosquito Day 22/08/2022 Raisa Santos To mark World Mosquito Day, 20 August, the Global Health Priority Box has been launched to provide free access to 240 compounds to stimulate research into new drugs and insecticides. The initiative, launched by the Medicines for Malaria Venture (MMV) and the Innovative Vector Control Consortium (IVCC), provides scientists with starting points to advance the […] Continue reading -> WHO Recommends Two Monoclonal Antibodies for Ebola Treatment; Calls to Expand Access in Developing Countries 19/08/2022 John Heilprin In its first guidelines ever for Ebola treatment, the World Health Organization (WHO) advises using two monoclonal antibodies — mAb114 (Ansuvimab®, also known as Ebanga®) and REGN-EB3 (Inmazeb®) — that were first approved by the US Food and Drug Administration for use against the Zaire ebolavirus species in 2020. WHO says its “strong recommendations” for […] Continue reading -> How Can Social Innovation Improve Life in Rural Communities? 19/08/2022 Editorial team When Dr. Magaly Blas, an Associate Professor at the Universidad Peruana Cayetano Heredia in Peru, was researching the association between the human papillomavirus that causes cervical cancer and the human T-lymphotropic virus that causes leukaemia, she found herself travelling often to the Amazon region of Ucayali, home to an indigenous community among whom the disease […] Continue reading -> Monkeypox Cases Spike 20% Weekly Worldwide 17/08/2022 John Heilprin As the first monkeypox case involving a human-to-dog transmission reported, the World Health Organization (WHO) said more than 35,000 recently confirmed cases of monkeypox were accompanied by 12 deaths in 92 nations and territories, including almost 7,500 from last week alone. That made for the second consecutive week with a 20% increase, WHO Director-General Dr […] Continue reading -> Early Neglect of Monkeypox is Rooted in Homophobia 15/08/2022 Michael Weinstein With COVID still upon us, it is hard to fathom why we have waited so long to address monkeypox. A cardinal rule of public health is to catch an emerging epidemic at the first instance it appears. Monkeypox, which was isolated in a few countries in Africa, leapt to Europe in early May and is […] Continue reading -> Exclusive: Manufacturer of World’s Only Monkeypox Drug Says There’s No Shortage; Will Work with WHO on Supplies to LMICs 12/08/2022 Stefan Anderson & Elaine Ruth Fletcher Top executives at Bavarian Nordic, which makes the world’s only monkeypox vaccine, avoided news media in the face of a worldwide shortage of their product. But SIGA, the company behind the antiviral treatment Tecovirimat (TPOXX™), has not been so shy. In an exclusive interview, SIGA’s CEO, Phillip Gomez, says the small, speciality firm is prepared […] Continue reading -> Despite Reforms, WHO ‘Prequalification’ Program for Vital Medicines and Diagnostics Is Inconsistent and Full of Delays 11/08/2022 Raisa Santos & Elaine Ruth Fletcher Recent reforms to the World Health Organization “prequalification” program that certifies the safety and efficacy of health products procured in bulk by donors for low and middle-income countries have speeded up the process and thus accelerated access to lifesaving medicines and diagnostic tools in low- and middle-income countries. However, long lead times for product approvals, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Open Access 240 Compound Collection Launched in Fight Against Infectious and Mosquito-Borne Illnesses for World Mosquito Day 22/08/2022 Raisa Santos To mark World Mosquito Day, 20 August, the Global Health Priority Box has been launched to provide free access to 240 compounds to stimulate research into new drugs and insecticides. The initiative, launched by the Medicines for Malaria Venture (MMV) and the Innovative Vector Control Consortium (IVCC), provides scientists with starting points to advance the […] Continue reading -> WHO Recommends Two Monoclonal Antibodies for Ebola Treatment; Calls to Expand Access in Developing Countries 19/08/2022 John Heilprin In its first guidelines ever for Ebola treatment, the World Health Organization (WHO) advises using two monoclonal antibodies — mAb114 (Ansuvimab®, also known as Ebanga®) and REGN-EB3 (Inmazeb®) — that were first approved by the US Food and Drug Administration for use against the Zaire ebolavirus species in 2020. WHO says its “strong recommendations” for […] Continue reading -> How Can Social Innovation Improve Life in Rural Communities? 19/08/2022 Editorial team When Dr. Magaly Blas, an Associate Professor at the Universidad Peruana Cayetano Heredia in Peru, was researching the association between the human papillomavirus that causes cervical cancer and the human T-lymphotropic virus that causes leukaemia, she found herself travelling often to the Amazon region of Ucayali, home to an indigenous community among whom the disease […] Continue reading -> Monkeypox Cases Spike 20% Weekly Worldwide 17/08/2022 John Heilprin As the first monkeypox case involving a human-to-dog transmission reported, the World Health Organization (WHO) said more than 35,000 recently confirmed cases of monkeypox were accompanied by 12 deaths in 92 nations and territories, including almost 7,500 from last week alone. That made for the second consecutive week with a 20% increase, WHO Director-General Dr […] Continue reading -> Early Neglect of Monkeypox is Rooted in Homophobia 15/08/2022 Michael Weinstein With COVID still upon us, it is hard to fathom why we have waited so long to address monkeypox. A cardinal rule of public health is to catch an emerging epidemic at the first instance it appears. Monkeypox, which was isolated in a few countries in Africa, leapt to Europe in early May and is […] Continue reading -> Exclusive: Manufacturer of World’s Only Monkeypox Drug Says There’s No Shortage; Will Work with WHO on Supplies to LMICs 12/08/2022 Stefan Anderson & Elaine Ruth Fletcher Top executives at Bavarian Nordic, which makes the world’s only monkeypox vaccine, avoided news media in the face of a worldwide shortage of their product. But SIGA, the company behind the antiviral treatment Tecovirimat (TPOXX™), has not been so shy. In an exclusive interview, SIGA’s CEO, Phillip Gomez, says the small, speciality firm is prepared […] Continue reading -> Despite Reforms, WHO ‘Prequalification’ Program for Vital Medicines and Diagnostics Is Inconsistent and Full of Delays 11/08/2022 Raisa Santos & Elaine Ruth Fletcher Recent reforms to the World Health Organization “prequalification” program that certifies the safety and efficacy of health products procured in bulk by donors for low and middle-income countries have speeded up the process and thus accelerated access to lifesaving medicines and diagnostic tools in low- and middle-income countries. However, long lead times for product approvals, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Recommends Two Monoclonal Antibodies for Ebola Treatment; Calls to Expand Access in Developing Countries 19/08/2022 John Heilprin In its first guidelines ever for Ebola treatment, the World Health Organization (WHO) advises using two monoclonal antibodies — mAb114 (Ansuvimab®, also known as Ebanga®) and REGN-EB3 (Inmazeb®) — that were first approved by the US Food and Drug Administration for use against the Zaire ebolavirus species in 2020. WHO says its “strong recommendations” for […] Continue reading -> How Can Social Innovation Improve Life in Rural Communities? 19/08/2022 Editorial team When Dr. Magaly Blas, an Associate Professor at the Universidad Peruana Cayetano Heredia in Peru, was researching the association between the human papillomavirus that causes cervical cancer and the human T-lymphotropic virus that causes leukaemia, she found herself travelling often to the Amazon region of Ucayali, home to an indigenous community among whom the disease […] Continue reading -> Monkeypox Cases Spike 20% Weekly Worldwide 17/08/2022 John Heilprin As the first monkeypox case involving a human-to-dog transmission reported, the World Health Organization (WHO) said more than 35,000 recently confirmed cases of monkeypox were accompanied by 12 deaths in 92 nations and territories, including almost 7,500 from last week alone. That made for the second consecutive week with a 20% increase, WHO Director-General Dr […] Continue reading -> Early Neglect of Monkeypox is Rooted in Homophobia 15/08/2022 Michael Weinstein With COVID still upon us, it is hard to fathom why we have waited so long to address monkeypox. A cardinal rule of public health is to catch an emerging epidemic at the first instance it appears. Monkeypox, which was isolated in a few countries in Africa, leapt to Europe in early May and is […] Continue reading -> Exclusive: Manufacturer of World’s Only Monkeypox Drug Says There’s No Shortage; Will Work with WHO on Supplies to LMICs 12/08/2022 Stefan Anderson & Elaine Ruth Fletcher Top executives at Bavarian Nordic, which makes the world’s only monkeypox vaccine, avoided news media in the face of a worldwide shortage of their product. But SIGA, the company behind the antiviral treatment Tecovirimat (TPOXX™), has not been so shy. In an exclusive interview, SIGA’s CEO, Phillip Gomez, says the small, speciality firm is prepared […] Continue reading -> Despite Reforms, WHO ‘Prequalification’ Program for Vital Medicines and Diagnostics Is Inconsistent and Full of Delays 11/08/2022 Raisa Santos & Elaine Ruth Fletcher Recent reforms to the World Health Organization “prequalification” program that certifies the safety and efficacy of health products procured in bulk by donors for low and middle-income countries have speeded up the process and thus accelerated access to lifesaving medicines and diagnostic tools in low- and middle-income countries. However, long lead times for product approvals, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
How Can Social Innovation Improve Life in Rural Communities? 19/08/2022 Editorial team When Dr. Magaly Blas, an Associate Professor at the Universidad Peruana Cayetano Heredia in Peru, was researching the association between the human papillomavirus that causes cervical cancer and the human T-lymphotropic virus that causes leukaemia, she found herself travelling often to the Amazon region of Ucayali, home to an indigenous community among whom the disease […] Continue reading -> Monkeypox Cases Spike 20% Weekly Worldwide 17/08/2022 John Heilprin As the first monkeypox case involving a human-to-dog transmission reported, the World Health Organization (WHO) said more than 35,000 recently confirmed cases of monkeypox were accompanied by 12 deaths in 92 nations and territories, including almost 7,500 from last week alone. That made for the second consecutive week with a 20% increase, WHO Director-General Dr […] Continue reading -> Early Neglect of Monkeypox is Rooted in Homophobia 15/08/2022 Michael Weinstein With COVID still upon us, it is hard to fathom why we have waited so long to address monkeypox. A cardinal rule of public health is to catch an emerging epidemic at the first instance it appears. Monkeypox, which was isolated in a few countries in Africa, leapt to Europe in early May and is […] Continue reading -> Exclusive: Manufacturer of World’s Only Monkeypox Drug Says There’s No Shortage; Will Work with WHO on Supplies to LMICs 12/08/2022 Stefan Anderson & Elaine Ruth Fletcher Top executives at Bavarian Nordic, which makes the world’s only monkeypox vaccine, avoided news media in the face of a worldwide shortage of their product. But SIGA, the company behind the antiviral treatment Tecovirimat (TPOXX™), has not been so shy. In an exclusive interview, SIGA’s CEO, Phillip Gomez, says the small, speciality firm is prepared […] Continue reading -> Despite Reforms, WHO ‘Prequalification’ Program for Vital Medicines and Diagnostics Is Inconsistent and Full of Delays 11/08/2022 Raisa Santos & Elaine Ruth Fletcher Recent reforms to the World Health Organization “prequalification” program that certifies the safety and efficacy of health products procured in bulk by donors for low and middle-income countries have speeded up the process and thus accelerated access to lifesaving medicines and diagnostic tools in low- and middle-income countries. However, long lead times for product approvals, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Monkeypox Cases Spike 20% Weekly Worldwide 17/08/2022 John Heilprin As the first monkeypox case involving a human-to-dog transmission reported, the World Health Organization (WHO) said more than 35,000 recently confirmed cases of monkeypox were accompanied by 12 deaths in 92 nations and territories, including almost 7,500 from last week alone. That made for the second consecutive week with a 20% increase, WHO Director-General Dr […] Continue reading -> Early Neglect of Monkeypox is Rooted in Homophobia 15/08/2022 Michael Weinstein With COVID still upon us, it is hard to fathom why we have waited so long to address monkeypox. A cardinal rule of public health is to catch an emerging epidemic at the first instance it appears. Monkeypox, which was isolated in a few countries in Africa, leapt to Europe in early May and is […] Continue reading -> Exclusive: Manufacturer of World’s Only Monkeypox Drug Says There’s No Shortage; Will Work with WHO on Supplies to LMICs 12/08/2022 Stefan Anderson & Elaine Ruth Fletcher Top executives at Bavarian Nordic, which makes the world’s only monkeypox vaccine, avoided news media in the face of a worldwide shortage of their product. But SIGA, the company behind the antiviral treatment Tecovirimat (TPOXX™), has not been so shy. In an exclusive interview, SIGA’s CEO, Phillip Gomez, says the small, speciality firm is prepared […] Continue reading -> Despite Reforms, WHO ‘Prequalification’ Program for Vital Medicines and Diagnostics Is Inconsistent and Full of Delays 11/08/2022 Raisa Santos & Elaine Ruth Fletcher Recent reforms to the World Health Organization “prequalification” program that certifies the safety and efficacy of health products procured in bulk by donors for low and middle-income countries have speeded up the process and thus accelerated access to lifesaving medicines and diagnostic tools in low- and middle-income countries. However, long lead times for product approvals, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Early Neglect of Monkeypox is Rooted in Homophobia 15/08/2022 Michael Weinstein With COVID still upon us, it is hard to fathom why we have waited so long to address monkeypox. A cardinal rule of public health is to catch an emerging epidemic at the first instance it appears. Monkeypox, which was isolated in a few countries in Africa, leapt to Europe in early May and is […] Continue reading -> Exclusive: Manufacturer of World’s Only Monkeypox Drug Says There’s No Shortage; Will Work with WHO on Supplies to LMICs 12/08/2022 Stefan Anderson & Elaine Ruth Fletcher Top executives at Bavarian Nordic, which makes the world’s only monkeypox vaccine, avoided news media in the face of a worldwide shortage of their product. But SIGA, the company behind the antiviral treatment Tecovirimat (TPOXX™), has not been so shy. In an exclusive interview, SIGA’s CEO, Phillip Gomez, says the small, speciality firm is prepared […] Continue reading -> Despite Reforms, WHO ‘Prequalification’ Program for Vital Medicines and Diagnostics Is Inconsistent and Full of Delays 11/08/2022 Raisa Santos & Elaine Ruth Fletcher Recent reforms to the World Health Organization “prequalification” program that certifies the safety and efficacy of health products procured in bulk by donors for low and middle-income countries have speeded up the process and thus accelerated access to lifesaving medicines and diagnostic tools in low- and middle-income countries. However, long lead times for product approvals, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Exclusive: Manufacturer of World’s Only Monkeypox Drug Says There’s No Shortage; Will Work with WHO on Supplies to LMICs 12/08/2022 Stefan Anderson & Elaine Ruth Fletcher Top executives at Bavarian Nordic, which makes the world’s only monkeypox vaccine, avoided news media in the face of a worldwide shortage of their product. But SIGA, the company behind the antiviral treatment Tecovirimat (TPOXX™), has not been so shy. In an exclusive interview, SIGA’s CEO, Phillip Gomez, says the small, speciality firm is prepared […] Continue reading -> Despite Reforms, WHO ‘Prequalification’ Program for Vital Medicines and Diagnostics Is Inconsistent and Full of Delays 11/08/2022 Raisa Santos & Elaine Ruth Fletcher Recent reforms to the World Health Organization “prequalification” program that certifies the safety and efficacy of health products procured in bulk by donors for low and middle-income countries have speeded up the process and thus accelerated access to lifesaving medicines and diagnostic tools in low- and middle-income countries. However, long lead times for product approvals, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Despite Reforms, WHO ‘Prequalification’ Program for Vital Medicines and Diagnostics Is Inconsistent and Full of Delays 11/08/2022 Raisa Santos & Elaine Ruth Fletcher Recent reforms to the World Health Organization “prequalification” program that certifies the safety and efficacy of health products procured in bulk by donors for low and middle-income countries have speeded up the process and thus accelerated access to lifesaving medicines and diagnostic tools in low- and middle-income countries. However, long lead times for product approvals, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy